This website is owned and operated by a private company - - Free Grant Money, Free Housing Grants, Free Personal Grants

Predictive in vitro Methods for Characterizing Product Performance, Case Study: Furosemide (U01)

Post Date

June 9th 2014

Application Due Date

July 15th 2014

Funding Opportunity Number


CFDA Number(s)


Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Consumer Protection
Food and Nutrition

Number of Awards


Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.


  • Estimated Total Funding:


  • Award Range:

    $None - $100000

Grant Description

This project follows after earlier CDER research projects in which in vitro furosemide dissolution and/or solubility data were collected in various dissolution media such as simulated gastric and intestinal fluids. In two different studies with different approaches and dissolution testing apparatus, furosemide dissolution was higher in medium containing milk and baby formula than that in standard buffer medium. This research project will explore additional methodology to characterize dissolution of furosemide (the model drug) in media containing milk, baby formula and Ensure Plusâ•™. The suitability of methods including the in vitro methods using dissolution media containing milk, baby formula and Ensure Plus for predicting in vivo performance of furosemide (a poorly soluble and poorly permeable drug), classified as BCS (Biopharmaceutic Classification System) Class IV drug will be explored and determined.

Contact Information

  • Agency

    Department of Health and Human Services

  • Office:

    Food and Drug Administration

  • Agency Contact:

    Lisa Ko
    Grants Management Specialist

  • Agency Mailing Address:

  • Agency Email Address:

  • More Information:

    Full Announcement RFA-FD-14-080

Grant checklist

Get A Free Grant Assistance KitRed triangle

To start your application for a free grant package go to:

Apply For Government Grant